The evaluation of vaccination status and the factors affecting vaccination in cancer patients

Muslih Ürün, I. Beypınar, S. E. Davarcı, H. Demir, M. Baykara
{"title":"The evaluation of vaccination status and the factors affecting vaccination in cancer patients","authors":"Muslih Ürün, I. Beypınar, S. E. Davarcı, H. Demir, M. Baykara","doi":"10.30565/medalanya.1094182","DOIUrl":null,"url":null,"abstract":"Background and aim: \nCoronavirus disease 2019 (COVID-19) pandemic increased the mortality of cancer patients by causing direct infection or collateral damage to the healthcare system. After the development of effective vaccines against COVID-19 infection, mortality rates declined. In this study, we try to investigate the vaccination among cancer patients. \nMaterial and Methods: \nA survey was applied to patients with cancer in order to investigate the attitudes towards vaccination and the factors effecting vaccination in two medical oncology centers in Turkey. \nResults: \n271 patients were included in the study. No difference was observed in the attitudes of patients towards vaccination according to cancer type. 83% of the patients were vaccinated against COVID-19. In 75% of the study population, vaccine was administered in the earliest available time. Receiving chemotherapy was the most significant reason to avoid vaccination among the study group (p=0,002). There was no significant difference in terms of treatment type for COVID-19 between patients with or without adequate vaccination. The most negative factor affecting vaccination was active chemotherapy treatment. Social relations and traditional media were the most positive factors for vaccination. \nDiscussion: \nVaccination is of vital importance for patients who are treated or on remission. Even if patients are to receive chemotherapy, they should be informed about vaccination and should be encouraged for vaccination.","PeriodicalId":7003,"journal":{"name":"Acta Medica Alanya","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Alanya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30565/medalanya.1094182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aim: Coronavirus disease 2019 (COVID-19) pandemic increased the mortality of cancer patients by causing direct infection or collateral damage to the healthcare system. After the development of effective vaccines against COVID-19 infection, mortality rates declined. In this study, we try to investigate the vaccination among cancer patients. Material and Methods: A survey was applied to patients with cancer in order to investigate the attitudes towards vaccination and the factors effecting vaccination in two medical oncology centers in Turkey. Results: 271 patients were included in the study. No difference was observed in the attitudes of patients towards vaccination according to cancer type. 83% of the patients were vaccinated against COVID-19. In 75% of the study population, vaccine was administered in the earliest available time. Receiving chemotherapy was the most significant reason to avoid vaccination among the study group (p=0,002). There was no significant difference in terms of treatment type for COVID-19 between patients with or without adequate vaccination. The most negative factor affecting vaccination was active chemotherapy treatment. Social relations and traditional media were the most positive factors for vaccination. Discussion: Vaccination is of vital importance for patients who are treated or on remission. Even if patients are to receive chemotherapy, they should be informed about vaccination and should be encouraged for vaccination.
肿瘤患者疫苗接种状况及影响因素评价
背景与目的:2019冠状病毒病(COVID-19)大流行通过对医疗保健系统造成直接感染或附带损害,增加了癌症患者的死亡率。在研发出针对COVID-19感染的有效疫苗后,死亡率有所下降。在这项研究中,我们试图调查癌症患者的疫苗接种情况。材料和方法:对土耳其两家肿瘤医学中心的癌症患者进行调查,以调查他们对疫苗接种的态度和影响疫苗接种的因素。结果:271例患者纳入研究。不同癌症类型患者对疫苗接种的态度无差异。83%的患者接种了COVID-19疫苗。在75%的研究人群中,疫苗在最早可用的时间内接种。接受化疗是研究组避免接种疫苗的最重要原因(p= 0.002)。接种疫苗或未接种疫苗的患者在COVID-19治疗类型方面无显著差异。影响疫苗接种的最不利因素是积极的化疗。社会关系和传统媒体是接种疫苗最积极的因素。讨论:疫苗接种是至关重要的病人谁是治疗或缓解。即使病人接受化疗,也应告知他们接种疫苗,并应鼓励他们接种疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信